Filter Results:
(611)
Show Results For
- All HBS Web
(1,023)
- People (4)
- News (256)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(1,023)
- People (4)
- News (256)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Sort by
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several... View Details
Keywords: by Manda Salls
- 04 Feb 2014
- First Look
First Look: February 4
system. It's complicated, takes a long time, and is very expensive. Should FasterCures reorganize to better understand this issue and make a high-level push to improve it? Or perhaps the company should look at drug reimbursement... View Details
Keywords: Sean Silverthlorne
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
media to engage others and build campaigns for change in the company. This case follows her career at the company and describes the challenges she faced as a change agent, working to promote gender equality within the company and a new View Details
Keywords: Dina Gerdeman
- 21 Aug 2018
- First Look
New Research and Ideas, August 21, 2018
growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby largely... View Details
Keywords: Dina Gerdeman
- 08 Nov 2016
- First Look
November 8, 2016
foods, which had previously been colored with dyes extracted from natural plants and organic minerals, helping them to achieve mass production and mass marketing. Color was easier to control, reproduce, and commoditize than other sensory factors such as smell and... View Details
Keywords: Sean Silverthorne
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
drug business. They relied, however, on licensing rather than building their own in-house capabilities for drug discovery and commercialization. In the low-tech OTC [over-the-counter] sector, they... View Details
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers association, Frazier has led the... View Details
Keywords: by Bill George
- 14 Dec 2011
- Research & Ideas
The New Measures for Improving Nonprofit Performance
using systems thinking and complexity theory to help us understand the challenges at the ecosystem level. There's also growing attention to using randomized control trials in the social sector, which we tend to associate with drug trials.... View Details
Keywords: by Julia Hanna
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
care, but there is another cost to be accounted for. Germany May Have the Answer for Reducing Drug PricesIn Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Making Health Insurance... View Details
- 11 Jan 2017
- Research & Ideas
The Paradoxical Quest to Make Food Look 'Natural' With Artificial Dyes
chromate was used to make milk look creamier; and various poisonous ingredients were used to create bright colors for various candies, reportedly causing some children to fall ill or even die. Hisano highlights key dates in food coloring regulation history. The Food... View Details
Keywords: by Carmen Nobel
- 28 Jul 2015
- First Look
First Look: July 28, 2015
of Dublin, Ireland-based Elan Drug Technologies (EDT)-a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information about the planned merger, and details the funding options. The case... View Details
Keywords: Carmen Nobel
- 09 Apr 2012
- Research & Ideas
Who Sways the USDA on GMO Approvals?
Other Agencies Influence Approvals In the case of procedural legitimacy, the researchers found a strong influence from an unlikely source—the USDA's sister agency, the Food and Drug Administration. In the process of approving GMOs,... View Details
- 10 Nov 2020
- Sharpening Your Skills
Research News and Tips: Innovating Across Time Zones
Dany Bahar, Prithwiraj Choudhury, and Britta Glennon. Drugs approved in December are associated with more adverse effects New research reveals that drug approvals surge in the US in December, at month-ends,... View Details
Keywords: by Sean Silverthorne
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In an adaptive platform trial, for example, different View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
- 08 Mar 2016
- First Look
March 8, 2016
cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details
Keywords: Sean Silverthorne
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
invasive surgery, radiation, and chemotherapy for cancer, for example) with drugs that can palliate and perhaps cure genetically-linked diseases. But like most new technologies, these are hugely expensive to develop, and initially, to... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or “large-molecule drugs”) represent a substantial and growing share of the U.S. drug market, accounting... View Details
Keywords: Sean Silverthorne
- 20 Dec 2018
- Research & Ideas
Most Popular Stories and Research Papers of 2018
Cirrus Foroughi, and Barbara Larson. Developing Novel Drugs This paper by Joshua Krieger and colleagues contributes to our understanding of how financing constraints affect the direction of innovation in View Details
Keywords: by Sean Silverthorne